Geen enkel medisch, therapeutisch, diagnostisch of preventief gebruik wordt geclaimd of gesuggereerd
doi: 10.3389/fendo.2023.1174692 31 LiDWangTShenSFangZDongYTangH
Mol Pharm (2008) 5(6):112230.10.1021/mp8001655 45 WuenschTUllrichSSchulzSChamaillardMSchaltenbergNRathEet alColonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation
By comparison, people taking Wegovy lost about 15% in 68 weeks (about a year and four months)
In contrast, semaglutide at a dose of 2.4 mg per week for 68 weeks resulted in a 14.915.6% weight loss in non-diabetic individuals with overweight or obesity, also with an average BMI of approximately 38 [11, 12], demonstrating a stronger anti-obesity effect with semaglutide than with liraglutide
Oral works best for digestive issues